Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
The short‐term use of erythropoetin‐stimulating agents: impact on the biochemical recurrence of prostate cancer
6
Zitationen
6
Autoren
2011
Jahr
Abstract
The short-term use of ESAs as a preoperative blood management strategy for patients undergoing ORRP has no clinically relevant adverse effects on the biology of prostate cancer. The present study supports the use of these agents before the procedure in patients undergoing surgery for localized disease.
Ähnliche Arbeiten
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
1996 · 22.204 Zit.
Anemia of Chronic Disease
2005 · 3.718 Zit.
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
2006 · 2.738 Zit.
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 · 2.179 Zit.
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
2006 · 2.091 Zit.